Keywords: مقاومت سیس پلاتین; Hexokinase 2; Ovarian cancer; Cisplatin resistance; Autophagy;
مقالات ISI مقاومت سیس پلاتین (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: مقاومت سیس پلاتین; Oral squamous cell carcinoma; Toll-like receptors; microRNA-146a; CARD10; Cisplatin resistance;
Keywords: مقاومت سیس پلاتین; Glutathione transferases; Fluorescent probe; Cellular imaging; Cisplatin resistance;
Keywords: مقاومت سیس پلاتین; Fibronectin 1; Cisplatin resistance; Apoptosis; Migration; Non-small cell lung cancerFN, Fibronectin; NSCLC, non-small cell lung cancer; IC50, 50% inhibitory concentration; ABC, ATP-binding cassette; FBS, fetal bovine serum; A490, absorbance at 490 nm; ΔΔ
Keywords: مقاومت سیس پلاتین; Cisplatin resistance; Pt(IV) prodrug; Cationic nanoparticle; Lung cancer
Keywords: مقاومت سیس پلاتین; Ormeloxifene; Novel therapies; Cisplatin resistance; Ovarian cancer; Apoptosis; Xenograft mice;
Keywords: مقاومت سیس پلاتین; 2-D WB; Mini-2D Western blotting analysis; Cisplatin; Cis-diamminedichloroplatinum (II); eIF5A; Eukaryotic initiation factor 5A-1; Hsp70; Heat shock protein 70Â kDa; MTT; 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide; Aaptamine; Marine alka
Loss of C/EBP-β LIP drives cisplatin resistance in malignant pleural mesothelioma
Keywords: مقاومت سیس پلاتین; ANOVA; analysis of variance; ATF6; activating transcription factor 6; C/EBP; CAAT/enhancer binding protein; IRE1; inositol-requiring enzyme 1; CHOP/GADD153; C/EBP homologous protein/growth arrest/DNA damage inducible 153; CEA; carcino-embrionic antigen; C
AJUBA increases the cisplatin resistance through hippo pathway in cervical cancer
Keywords: مقاومت سیس پلاتین; YAP; Yes-associated protein; Lats1/2; large tumor suppressor; ESCC; esophageal squamous cell carcinoma; IHC; immunohistochemistry; EMT; epithelial-to-mesenchymal transition; Cervical cancer; AJUBA; Cisplatin resistance; Hippo signaling pathway;
DUOXA1-mediated ROS production promotes cisplatin resistance by activating ATR-Chk1 pathway in ovarian cancer
Keywords: مقاومت سیس پلاتین; ROS; High throughput screen; Cisplatin resistance; Ovarian cancer; DUOXA1; ATR-Chk1; qHTCS; quantitative high throughput combinational screen; RNA-seq; RNA-sequencing; DUOXA1; dual oxidase maturation factor 1; ROS; reactive oxygen species;
Small-molecule compounds targeting the STAT3 DNA-binding domain suppress survival of cisplatin-resistant human ovarian cancer cells by inducing apoptosis
Keywords: مقاومت سیس پلاتین; Signal transducer and activator of transcription 3 (STAT3); DNA binding domain (DBD); Similarity screening; Microscale thermophoresis; Cisplatin resistance;
BBI608 inhibits cancer stemness and reverses cisplatin resistance in NSCLC
Keywords: مقاومت سیس پلاتین; Non-small cell lung cancer; Chemotherapy; Cisplatin resistance; Cancer stem cells; Aldehyde dehydrogenase; BBI608; NSCLC; non-small cell lung cancer; ALDH; aldehyde dehydrogenase; CSC; cancer stem cell; STAT3; signal transducer and activator of transcript
Soft drug-resistant ovarian cancer cells migrate via two distinct mechanisms utilizing myosin II-based contractility
Keywords: مقاومت سیس پلاتین; OCCs; ovarian cancer cells; DS; drug-sensitive; CisR; cisplatin-resistant; PacR; paclitaxel-resistant; Dual; dual drug-resistant; MMPs; matrix metalloproteinases; pMLC; phosphorylated myosin light chain; MLC; myosin light chain; GM; GM6001; NMM II; non-mu
Integrated proteomic and phosphoproteomic analyses of cisplatin-sensitive and resistant bladder cancer cells reveal CDK2 network as a key therapeutic target
Keywords: مقاومت سیس پلاتین; Global proteome; Phosphoproteomics; Cisplatin resistance; Bladder cancer; Biological network; Competing interests;
Rapid induction of apoptosis in tumor cells treated with a new platinum(II) complex based on amino-thiazolidinone
Keywords: مقاومت سیس پلاتین; Platinum(II) complexes; Cisplatin resistance; Rapid apoptosis; Pt/Cu uptake; Amino-thiazolidinone;
Salvianolic acid A reverses cisplatin resistance in lung cancer A549 cells by targeting c-met and attenuating Akt/mTOR pathway
Keywords: مقاومت سیس پلاتین; Salvianolic acid A; Cisplatin resistance; Lung cancer; c-Met; Reversal mechanism;
Original articleIncreased intracellular Ca2+ decreases cisplatin resistance by regulating iNOS expression in human ovarian cancer cells
Keywords: مقاومت سیس پلاتین; Ovarian cancer; Cisplatin resistance; Intracellular Ca2+; iNOS;
ABT737 induces mitochondrial pathway apoptosis and mitophagy by regulating DRP1-dependent mitochondrial fission in human ovarian cancer cells
Keywords: مقاومت سیس پلاتین; Ovarian cancer; Cisplatin resistance; Mitochondrial fission; Apoptosis; Mitophagy; ABT737;
Encapsulation of cisplatin in a pegylated calcium phosphate nanoparticle (CPNP) for enhanced cytotoxicity to cancerous cells
Keywords: مقاومت سیس پلاتین; Calcium phosphate nanoparticle (CPNP); Cisplatin; Drug delivery; Encapsulation; Premature release; Cisplatin resistance;
Anticancer activity of hydroxy- and sulfonamide-azobenzene platinum(II) complexes in cisplatin-resistant ovarian cancer cells
Keywords: مقاومت سیس پلاتین; Cisplatin; Cisplatin resistance; Antitumor drug; Ovarian cancer; Azobenzene; Photodynamic therapy;
An Oncofetal Glycosaminoglycan Modification Provides Therapeutic Access to Cisplatin-resistant Bladder Cancer
Keywords: مقاومت سیس پلاتین; Bladder cancer; Cisplatin resistance; Malaria protein; Second-line therapy; Targeted therapy;
Reprint of “Anticancer activity of hydroxy- and sulfonamide-azobenzene platinum(II) complexes in cisplatin-resistant ovarian cancer cells”
Keywords: مقاومت سیس پلاتین; Cisplatin; Cisplatin resistance; Antitumor drug; Ovarian cancer; Azobenzene; Photodynamic therapy;
Original ArticleA CK2-targeted Pt(IV) prodrug to disrupt DNA damage response
Keywords: مقاومت سیس پلاتین; Pt(IV) complex; CK2; DSBs repair; Cisplatin resistance;
ERCC2/XPD Lys751Gln alter DNA repair efficiency of platinum-induced DNA damage through P53 pathway
Keywords: مقاومت سیس پلاتین; ERCC2/XPDLys751Glnrs13181; Nucleotide excision repair (NER); DNA repair capacity (DRC); Cisplatin resistance; Transfected cell model;
Overcoming cisplatin resistance in non-small cell lung cancer with Mad2 silencing siRNA delivered systemically using EGFR-targeted chitosan nanoparticles
Keywords: مقاومت سیس پلاتین; Cisplatin resistance; EGFR-targeted chitosan nanoparticles; Mad2 siRNA delivery; Non-small cell lung cancer models; Efficacy; Safety profile;
Horizontal transfer of miR-106a/b from cisplatin resistant hepatocarcinoma cells can alter the sensitivity of cervical cancer cells to cisplatin
Keywords: مقاومت سیس پلاتین; Cisplatin resistance; Exosomes; miR-106a/b; SIRT1;
Transmembrane protein 88 (TMEM88) promoter hypomethylation is associated with platinum resistance in ovarian cancer
Keywords: مقاومت سیس پلاتین; Ovarian cancer; DNA methylation; Cisplatin resistance; TMEM88; Wnt;
Activation of mitochondrial oxidation by PDK2 inhibition reverses cisplatin resistance in head and neck cancer
Keywords: مقاومت سیس پلاتین; HNC; head and neck cancer; DCA; dichloroacetate; CDDP; cisplatin; OXPHOS; oxidative phosphorylation; PDK2; pyruvate dehydrogenase kinase 2; PDHE1α; pyruvate dehydrogenase isoform E1α; ROS; reactive oxygen species; ÎΨm; mitochondrial membrane potential
Selective inhibition of tumor cell associated Vacuolar-ATPase 'a2' isoform overcomes cisplatin resistance in ovarian cancer cells
Keywords: مقاومت سیس پلاتین; Vacuolar ATPase; a2 isoform; Ovarian cancer; Cisplatin resistance;
Inhibition of autophagy by andrographolide resensitizes cisplatin-resistant non-small cell lung carcinoma cells via activation of the Akt/mTOR pathway
Keywords: مقاومت سیس پلاتین; NSCLC; Cisplatin resistance; Autophagy; Andrographolide; PTEN;
MicroRNA-24 induces cisplatin resistance by targeting PTEN in human tongue squamous cell carcinoma
Keywords: مقاومت سیس پلاتین; MicroRNA-24; PTEN; Cisplatin resistance; Tongue squamous carcinoma
Circumvention of cisplatin resistance in ovarian cancer by combination of cyclosporin A and low-intensity ultrasound
Keywords: مقاومت سیس پلاتین; Cisplatin resistance; Ovarian cancer; Ultrasound; Cyclosporin A; Chemosensitization; Survival;
Pharmacologic inhibition of ATR and ATM offers clinically important distinctions to enhancing platinum or radiation response in ovarian, endometrial, and cervical cancer cells
Keywords: مقاومت سیس پلاتین; DNA damage repair response; ATR; ATM; Gynecologic cancer; Cisplatin resistance; Ionizing radiation
Defects in DNA Repair Genes Predict Response to Neoadjuvant Cisplatin-based Chemotherapy in Muscle-invasive Bladder Cancer
Keywords: مقاومت سیس پلاتین; Bladder cancer; Urothelial carcinoma; Biomarkers; Cisplatin sensitivity; Cisplatin resistance; ATM; RB1; FANCC; DNA repair; Neoadjuvant chemotherapy
Inhibition of cisplatin-resistance by RNA interference targeting metallothionein using reducible oligo-peptoplex
Keywords: مقاومت سیس پلاتین; Cisplatin resistance; RNA interference; Metallothionein; Combination therapy
Combination Treatment with All-Trans Retinoic Acid Prevents Cisplatin-Induced Enrichment of CD133+ Tumor-Initiating Cells and Reveals Heterogeneity of Cancer Stem Cell Compartment in Lung Cancer
Keywords: مقاومت سیس پلاتین; Non-small-cell lung cancer; Retinoic acid; Cancer stem cells dynamics; Cisplatin resistance;
MicroRNA-31 inhibits cisplatin-induced apoptosis in non-small cell lung cancer cells by regulating the drug transporter ABCB9
Keywords: مقاومت سیس پلاتین; miR-31; ABCB9; Cisplatin resistance; Apoptosis; Non-small cell lung cancer;
Salinomycin inhibits Akt/NF-κB and induces apoptosis in cisplatin resistant ovarian cancer cells
Keywords: مقاومت سیس پلاتین; Salinomycin; Akt; Cisplatin resistance; Ovarian cancer; Apoptosis;
Histone deacetylase inhibition restores cisplatin sensitivity of Hodgkin's lymphoma cells
Keywords: مقاومت سیس پلاتین; Hodgkin's lymphoma; Histone deacetylase inhibitors; Gene expression; Interleukin-26; Cisplatin resistance
L1 cell adhesion molecule and epidermal growth factor receptor activation confer cisplatin resistance in intrahepatic cholangiocarcinoma cells
Keywords: مقاومت سیس پلاتین; EGFR; L1CAM; Cisplatin resistance; Intrahepatic cholangiocarcinoma
miR-513a-3p sensitizes human lung adenocarcinoma cells to chemotherapy by targeting GSTP1
Keywords: مقاومت سیس پلاتین; miRNA; Cisplatin resistance; A549; A549/CDDP; Chemotherapy; CCK-8 assay; GSTP1; miR-513a-3p;
Cancer stem-like cells contribute to cisplatin resistance and progression in bladder cancer
Keywords: مقاومت سیس پلاتین; Cancer stem-like cell; Bladder cancer; Cisplatin resistance; Epithelial–mesenchymal transition
Relevance of copper transporter 1 for cisplatin resistance in human ovarian carcinoma cells
Keywords: مقاومت سیس پلاتین; Cisplatin resistance; Cisplatin uptake; Copper transporter 1; Fluorescent cisplatin analogue;
Role of Insulin-Like Growth Factor-1 Signaling Pathway in Cisplatin-Resistant Lung Cancer Cells
Keywords: مقاومت سیس پلاتین; Cisplatin resistance; Insulin-like growth factor binding protein-3; IGFBP-3; Lung cancer; Radiotherapy;
Correlative nanomechanical profiling with super-resolution F-actin imaging reveals novel insights into mechanisms of cisplatin resistance in ovarian cancer cells
Keywords: مقاومت سیس پلاتین; Nanomechanics; Actin remodeling; Cisplatin resistance; Ovarian cancer; Stimulated emission depletion (STED)
Lipophilic Pt(II) complexes with selective efficacy against cisplatin-resistant testicular cancer cells
Keywords: مقاومت سیس پلاتین; Platinum complexes; Terpenes; Cisplatin resistance; Testicular cancer
Temsirolimus Inhibits Malignant Pleural Mesothelioma Growth In Vitro and In Vivo: Synergism with Chemotherapy
Keywords: مقاومت سیس پلاتین; Mesothelioma; mTOR; Temsirolimus; Chemotherapy; Cisplatin resistance
Biology of Germ Cell Tumors
Keywords: مقاومت سیس پلاتین; Testicular; Germ cell tumors; Biology; Cisplatin resistance;
Role of the Akt/mTOR survival pathway in cisplatin resistance in ovarian cancer cells
Keywords: مقاومت سیس پلاتین; Cisplatin resistance; Ovarian cancer cells; Akt; mTOR; Apoptosis
Relationship between molecular markers and treatment response in a retrospective cohort of Indian patients with primary carcinoma of the larynx
Keywords: مقاومت سیس پلاتین; p53 Mutation; Carcinoma of the larynx; Treatment response; Prognostic markers; Cisplatin resistance; Larynx preservation;